Intrahepatic Cholangiocarcinoma

Keyphrases

• Intrahepatic Cholangiocarcinoma (iCCA) 100%
• Risk Factors 66%
• Resection 33%
• Surgical Resection 33%
• Targeted Therapy 33%
• Metastatic Disease 33%
• Epithelial Cells 33%
• Physiologic 33%
• Highly Aggressive 33%
• Adjuvant Chemotherapy 33%
• Inflammatory Diseases 33%
• Long-term Survival 33%
• Survival Benefit 33%
• Prognostic Factors 33%
• Aggressive Tumor 33%
• Resectability 33%
• Porta Hepatis 33%
• Systemic Therapy 33%
• Lymphadenectomy 33%
• Hepatobiliary 33%
• Nodal Involvement 33%
• Locoregional Therapy 33%
• Chronic Hepatitis 33%
• Biliary Duct 33%
• Extrahepatic Bile Duct 33%
• Chronic Liver Cirrhosis 33%
• Fluke 33%
• Operative Plan 33%
• Intrahepatic Bile Duct 33%
• Unresectable Disease 33%
• Advanced Tumors 33%

Medicine and Dentistry

• Cholangiocarcinoma 100%
• Metastatic Carcinoma 33%
• Epithelial Cell 33%
• Targeted Therapy 33%
• Adjuvant Chemotherapy 33%
• Inflammatory Disorder 33%
• Bile Duct 33%
• Long Term Survival 33%
• Retroperitoneal Lymph Node Dissection 33%
• Prognostic Factor 33%
• Extrahepatic Bile Duct 33%
• Tumor 33%
• Chronic Hepatitis 33%
• Intrahepatic Bile Duct 33%
• Biliary Cirrhosis 33%
• Fluke 33%